Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03281850 · ClinicalTrials.gov registry record

The GLOWING Study: Growing Life, Optimizing Wellness 2

A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
212
Enrollment target

NCT03281850: Completed study, sponsored by Arkansas Children's Hospital Research Institute.

NCT03281850 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 212 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03281850 has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
212 participants
Enrollment target

Study Summary

This study will help us learn more about how maternal health can influence child health.

Primary Outcome

Using stable isotope techniques to determine energy expenditure

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2017-09-11
Est. Completion 2020-11-23

What the finished NCT03281850 record still lists

NCT03281850 is an observational study that tracks outcomes without assigning an intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT03281850 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03281850 about?

NCT03281850 is a clinical study titled "The GLOWING Study: Growing Life, Optimizing Wellness 2". This study will help us learn more about how maternal health can influence child health.

What is the current status of trial NCT03281850?

This trial is currently completed. The enrollment target is 212 participants. The study started on 2017-09-11. Estimated completion is 2020-11-23.

Who is sponsoring clinical trial NCT03281850?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

  • NCT06456593 · 212 participants · Phase 2

    Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03281850, the US trial registry maintained by the National Library of Medicine. NCT03281850 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.